JP2024546943A5 - - Google Patents

Info

Publication number
JP2024546943A5
JP2024546943A5 JP2024535914A JP2024535914A JP2024546943A5 JP 2024546943 A5 JP2024546943 A5 JP 2024546943A5 JP 2024535914 A JP2024535914 A JP 2024535914A JP 2024535914 A JP2024535914 A JP 2024535914A JP 2024546943 A5 JP2024546943 A5 JP 2024546943A5
Authority
JP
Japan
Prior art keywords
substituted
alkyl
halogen
heterocyclyl
halogens
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024535914A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024546943A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/081516 external-priority patent/WO2023114819A1/en
Publication of JP2024546943A publication Critical patent/JP2024546943A/ja
Publication of JP2024546943A5 publication Critical patent/JP2024546943A5/ja
Pending legal-status Critical Current

Links

JP2024535914A 2021-12-15 2022-12-14 Ｒｘｆｐ１アゴニストとしてのテトラリン、フェニルシクロブタン、およびフェニルシクロペンタン類似体 Pending JP2024546943A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163289812P 2021-12-15 2021-12-15
US63/289,812 2021-12-15
PCT/US2022/081516 WO2023114819A1 (en) 2021-12-15 2022-12-14 Tetraline, phenylcyclobutane, and phenylcyclopentane analogs as rxfp1 agonists

Publications (2)

Publication Number Publication Date
JP2024546943A JP2024546943A (ja) 2024-12-26
JP2024546943A5 true JP2024546943A5 (cg-RX-API-DMAC7.html) 2025-12-15

Family

ID=85321205

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024535914A Pending JP2024546943A (ja) 2021-12-15 2022-12-14 Ｒｘｆｐ１アゴニストとしてのテトラリン、フェニルシクロブタン、およびフェニルシクロペンタン類似体

Country Status (5)

Country Link
EP (1) EP4448484A1 (cg-RX-API-DMAC7.html)
JP (1) JP2024546943A (cg-RX-API-DMAC7.html)
KR (1) KR20240125946A (cg-RX-API-DMAC7.html)
CN (1) CN118401496A (cg-RX-API-DMAC7.html)
WO (1) WO2023114819A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117326961B (zh) * 2023-09-27 2024-05-03 安徽峆一药业股份有限公司 一种非苏拉赞中间体的绿色合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1614676A4 (en) * 2003-03-27 2009-03-25 Kirin Pharma Kk CONNECTION TO INHIBITING IN VIVO PHOSPHORUS TRANSPORT AND MEDICAMENT CONTAINING THEREOF
US9452973B2 (en) * 2012-05-04 2016-09-27 The United States Of America, As Represented By The Secretary Department Of Health And Human Services Modulators of the relaxin receptor 1

Similar Documents

Publication Publication Date Title
JP2024540164A5 (cg-RX-API-DMAC7.html)
JP2024540163A5 (cg-RX-API-DMAC7.html)
JP2024546943A5 (cg-RX-API-DMAC7.html)
JP2025501509A5 (cg-RX-API-DMAC7.html)
JP2010526145A5 (cg-RX-API-DMAC7.html)
JP2020526484A5 (cg-RX-API-DMAC7.html)
JP2009108048A (ja) 分子シャペロン産生を増強するのに有用なヒドロキシルアミン誘導体およびそれの調製
CN103370289A (zh) 4-羟基丁酸氘化类似物
JP2018508569A5 (cg-RX-API-DMAC7.html)
JP2005504121A5 (cg-RX-API-DMAC7.html)
JP2012522759A5 (cg-RX-API-DMAC7.html)
AU721355B2 (en) Novel compounds useful as neuro-protective agents
JP2022500473A5 (cg-RX-API-DMAC7.html)
JP2022530051A5 (cg-RX-API-DMAC7.html)
JP2022529806A5 (cg-RX-API-DMAC7.html)
KR890005031A (ko) L-도파유도체 또는 그의 산부가염, 그의 제조방법 및 그의 용도
JP2014505017A (ja) 脂質化合物を用いる処置方法
JP2024546944A5 (cg-RX-API-DMAC7.html)
JP2022545158A5 (cg-RX-API-DMAC7.html)
US5686621A (en) Substituted hydrindanes for the treatment of angiogenesis-dependent diseases
JP2023537062A5 (cg-RX-API-DMAC7.html)
JP2024546946A5 (cg-RX-API-DMAC7.html)
JP3110515B2 (ja) スルホンアミド誘導体
JP2024540161A5 (cg-RX-API-DMAC7.html)
JP2022537350A5 (cg-RX-API-DMAC7.html)